Royal Enfield Scrambler 650 teased again ahead of debut next week: What to expect?

With EICMA 2024 around the corners, the buzz around upcoming motorcycles has gained quite a bit of traction online. Most of the traction is centred around Royal Enfield which has been a prominent face at the annual motorcycle exhibition in Milan for the last few years. The Chennai-based bikemaker has ramped up its operations and presence in foreign markets in the past decade.

Hence, the palpable hype around every launch from Enfield is understandable. The Eicher subsidiary is gearing up to showcase a wide range of upcoming models at EICMA starting November 4. Some of them will be pre-production concepts while others will be the final production models. One of the latter is expected to be the new 650cc scrambler.

Royal Enfield Scrambler 650 details

Speculated to be named as Interceptor Bear 650, a patent of the same was leaked online a few weeks back. Royal Enfield has also filed a trademark for the same name in India. Test mules of the bike have been spied on numerous occasions in the past year or so. Recently the bike was teased by the company on its social media handles thus revealing its prospective debut at the EICMA.

Also Read David Warner’s lifetime leadership ban lifted by Cricket Australia – Here’s why the ban was imposed India vs New Zealand 2nd Test: Ravichandran Ashwin strikes early as India look to level series IND vs NZ 1st Test: New Zealand defeats India after dramatic final day chase India vs New Zealand: Jasprit Bumrah named Vice Captain for three-match Tests series

Royal Enfield Scrambler 650. (Image: FE)

The upcoming twin-cylinder scrambler has been teased once again in a new promotional video shared by Royal Enfield on its social media handles. As the same suggests, the Interceptor Bear will be based on the same chassis as Interceptor 650. Hence, we expect to find a lot of familiarity between the two models when the former is officially presented to the world at EICMA 2024 next week.

The most critical of them is the steel tubular chassis, however, the rear subframe in the scrambler is expected to be different from the roadster. Besides this, body panels, components and the overall design are also expected to remain unchanged. From previous spy shots and recent teasers it has been deduced that the upcoming Interceptor will get upside down front forks and twin rear shock absorbers,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth